Member Info for ChrisToffer

If phase 3 is successful and they sell anywhere near 100k a month treatments in the Western world then this is worth a hell of a lot more than £3 a share.

Pharma123 filtered!
What a load of old tripe!

That was only one step in the process that led them to where they are now. At the time of the asthma trial, they couldn't diagnose if exacerbations were being caused by bacteria or viruses. The results of the asthma trial informed the decision to investigate COPD where exacerbations would have a much more profound impact ob both patients and hospitals.

A lot of traders and a lot of wet sheets this morning. This is AIM lads and we're 5% down. We could be 5% down on any red day without news. If you can't handle that or need the company to hold your hand all the way through this process then maybe its not for you.

Computer909 filtered.

RM has went on record after the first vaccine announcements to say they expect to be treating patients in hospitals next winter. He also said NOT to contact him asking him to comment on other peoples news.

Dumbpunter filtered. Surprised its taken this long if i'm honest.

Dumbpunter, as you appear to be more skilled at interpreting peer reviews than all of the scientists that we've seen comment on the Lancet review; Can you point me to 1 peer reviewed covid therapeutic that shows greater promise than SNG001?

Spot on Dziny. All this talk of commercialisation is premature.

If people are concerned about the companies ability to commercialise the drug then they must be pretty confident it'll pass P3 with flying colours. P3 is the more immediate risk and one people should be assessing first.

If the outcome of that assessment is that it will pass P3 with flying colours then the drug will sell itself because its had the most promising P2 results of any covid therapeutic to date.

That's right Mat! That outcome from the COPD treatment also highlights the benefits of running this P3 through winter to help demonstrate the broad spectrum use!

'60% of the time, works all the time!'

Seb, you need to look beyond covid to see the potential of this drug and that is exactly what they're all telling us. When the market wakes up to that potential this will be worth a lot more than £2.

Before golf, the point is that he is well aware of it which for me means it is known about in the right circles. I suspect you want it plastered all over the MSM but thats no good to anyone until they get it approved.

Beforegolf, Tony Fauci has been on record talkng about the drugs progress. What correct circles are not aware of the drug?

Seb I think you're missing the point on this drugs potential value which has been repeated by RM, Stephen holgate and again tonight. Its not just for covid, but even if we look at its use for covid; it has the strongest data set of all treatments to date. You don't need to keep posting different analogies to get the point across, the point is you would prefer he took less than what he feels its worth.

Personally I'm prepared to have some patience and let him achieve maximum value for me as a shareholder.

The drop has not been through any misstep of the company. That is evidenced through similar related stocks all sufferring the same sentiment driven drops.

The fact remains that market value is under 200 million which is a little oversold (driven by sentiment) but for the most part it has been between 2-300 million since July 20th. Thats fair value until they get an approval or firm orders.

PMJHs post below shows that there has been plenty of press in the right circles and the company are firmly on NIHR and NIH/FDAs radar.

They can't market an unlicensed drug so what more do want exactly?

Seb/Doc/Parsley, help me understand this point. You think that RM holding out for what they believe is correct value for the drug, is a bad thing for shareholders?

It is illegal to market an unlicenced drug. SNG has had press releases around the P2 trial results and the peer review but it doesnt matter who they hire, they need more data.

The list of trials is here, https://www.nihr.ac.uk/covid-studies/

Thats the one to watch for the status change

Hi MagentaScarab,

Try here https://www.nihr.ac.uk/news/covid-19-treatment-results-published-in-journal-ahead-of-nihr-supported-phase-3-trial-of-nebulised-interferon-beta/26186

Thats dated 6th August Shan